Literature DB >> 8131706

Could immunostimulant drugs be useful in apparently medically refractory Crohn's disease?

G Nardone1, G Budillon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8131706     DOI: 10.1007/bf02088357

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  8 in total

Review 1.  Are the inflammatory bowel diseases autoimmune disorders?

Authors:  J Snook
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

2.  Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis.

Authors:  D S Levine; S H Fischer; D L Christie; R C Haggitt; H D Ochs
Journal:  Am J Gastroenterol       Date:  1992-01       Impact factor: 10.864

Review 3.  Lymphokines and the intestinal immune response. Role in inflammatory bowel disease.

Authors:  C Fiocchi
Journal:  Immunol Invest       Date:  1989 Jan-May       Impact factor: 3.657

4.  High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives.

Authors:  C Fiocchi; J K Roche; W M Michener
Journal:  Ann Intern Med       Date:  1989-05-15       Impact factor: 25.391

5.  Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease.

Authors:  A Raedler; S Fraenkel; G Klose; K Seyfarth; H G Thiele
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

6.  Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  D B Sachar; K P Rubin; V Gumaste
Journal:  Am J Gastroenterol       Date:  1987-06       Impact factor: 10.864

7.  Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.

Authors:  S P James; L M Neckers; A S Graeff; J Cossman; C M Balch; W Strober
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

Review 8.  New therapeutic agents in the treatment of inflammatory bowel disease.

Authors:  D L Geier; P B Miner
Journal:  Am J Med       Date:  1992-08       Impact factor: 4.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.